Bioxytran's total assets for Q1 2025 were $136.05K, a decrease of -1.90% from the previous quarter. BIXT total liabilities were $2.84M for the fiscal quarter, a 47.31% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.